What does PL 969/26 propose?

Bill 969/26, currently under review in Brazil's Chamber of Deputies, would make the HPV vaccine mandatory and shift the country's public screening approach for cervical cancer. The proposal covers both vaccination requirements and diagnostic upgrades within the SUS (Brazil's unified public health system).

Why would HPV vaccination become mandatory?

The Human Papillomavirus (HPV) is the leading cause of cervical cancer. Making the vaccine compulsory aims to increase coverage rates and protect a larger share of the population, particularly young people who currently rely on voluntary immunization campaigns.

How would cervical cancer screening change?

Beyond vaccination, the bill prioritizes molecular tests — such as HPV DNA testing — over traditional Pap smears within the SUS. Molecular tests are considered more sensitive and can detect high-risk strains of the virus earlier, potentially catching pre-cancerous changes before they develop.

What does this mean for expats and residents in Brazil?

Foreign nationals living in Brazil who use the SUS could benefit from improved screening protocols if the bill passes. Those on private health plans should check with their insurer about current HPV testing and vaccination coverage, as private providers may adopt similar standards over time.

What is the current status of the bill?

As of August 2026, PL 969/26 is still being analyzed by the Chamber of Deputies. It has not yet been voted on or signed into law. Expats and residents are encouraged to monitor updates through official Brazilian legislative channels.

Key Facts:
  • Bill PL 969/26 proposes mandatory HPV vaccination in Brazil.
  • The bill prioritizes molecular tests for cervical cancer screening in the SUS.
  • The proposal is currently under review at the Chamber of Deputies.
  • HPV (Human Papillomavirus) is the main cause of cervical cancer.